EDGAR Filing Documents for 0001607062-17-000256

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001607062-17-000256

Filing Date

2017-08-07

Accepted

2017-08-07 17:29:28

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	rgbp063017form10q.htm	10-Q	654479
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	61556
3	EXHIBIT 10.2	ex10_2.htm	EX-10.2	62726
4	EXHIBIT 10.3	ex10_3.htm	EX-10.3	31783
5	EXHIBIT 10.4	ex10_4.htm	EX-10.4	60866
6	EXHIBIT 10.5	ex10_5.htm	EX-10.5	75910
7	EXHIBIT 10.6	ex10_6.htm	EX-10.6	66208
8	EXHIBIT 10.7	ex10_7.htm	EX-10.7	41231
9	EXHIBIT 31.1	ex31_1.htm	EX-31.1	8129
10	EXHIBIT 31.2	ex31_2.htm	EX-31.2	7922
11	EXHIBIT 32.1	ex32_1.htm	EX-32.1	4703
12	EXHIBIT 32.2	ex32_2.htm	EX-32.2	4701
	Complete submission text file	0001607062-17-000256.txt		3394381

Data Files

Seq	Description	Document	Type	Size
13	XBRL INSTANCE FILE	rgbp-20170630.xml	EX-101.INS	483754
14	XBRL SCHEMA FILE	rgbp-20170630.xsd	EX-101.SCH	36829
15	XBRL CALCULATION FILE	rgbp-20170630_cal.xml	EX-101.CAL	35053
16	XBRL DEFINITION FILE	rgbp-20170630_def.xml	EX-101.DEF	151938
17	XBRL LABEL FILE	rgbp-20170630_lab.xml	EX-101.LAB	180643
18	XBRL PRESENTATION FILE	rgbp-20170630_pre.xml	EX-101.PRE	177148

Mailing Address 4700 SPRING ST #304 LA MESA CA 91942

Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404

Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)